Adrenal Disorders.

Slides:



Advertisements
Similar presentations
Adrenal Crisis in the ICU
Advertisements

Addison’s, Cushing’s & Acromegaly
Adrenal Dr Sohail Inam FRCP(Ed), FRCP Consultant Endocrinologist
Adrenocortical Functions - 2. Adrenocortical hypofunction Adrenocortical insufficiency may be: A.Primary B.Secondary.
Adrenocorticosteroids พญ. มาลียา มโนรถ. Adrenocorticosteroids Emotional stress Hypothalamus CRF Anterior pituitary gland ACTH Adrenal cortex Adrenal steroids.
Adrenocortical Functions. ANATOMICALLY: The adrenal gland is situated on the anteriosuperior aspect of the kidney and receives its blood supply from the.
Cushing syndrome.
Emergency Care: Addisonian Crisis & Adrenal Insufficiency.
Cushing’s Syndrome Britni Hebert PGY 2 4/9/10 Notes located in presenter note section below each slide.
Adrenal gland. ? What is the adrenal gland The adrenal glands (also known as suprarenal glands) are the triangle-shaped and orange- colored endocrine.
 Located above the kidneys like a hat for them.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 60 Drugs for Disorders of the Adrenal Cortex.
Adrenal Insufficiency UNC Internal Medicine Morning Report June 28, 2010 Edward L. Barnes, MD.
Focus on Addison’s Disease
Adrenocortical hormones
OST 529 Systems Biology: Endocrinology
The Adrenal Cortex. Basic principles of steroid endocrinology Steroid effects fall into 3 categories: –Mineralocorticoid –Glucocorticoid –Androgen/Estrogen.
Adrenal Insufficiency
Cushing’s syndrome 一40岁女性,自述近两年体重增加,尤其腹部,但体力却明显下降。到当地医院就诊时发现血压高、血糖高、血脂高、血钾低,对症治疗不见好转来诊。你考虑该患可能得了什么病?线索?为什么?还应做那些检查? 鉴别:2型糖尿病:类固醇性糖尿病:小剂量地塞米松抑制试验被抑制 代谢综合征:
Endocrine Physiology The Adrenal Gland 2 Dr. Khalid Alregaiey.
KEY TERMS DX TESTS RISK FACTORS CANCER PATHOPHYS HODGE-
Hypercortisolism (Cushing’ s Syndrome)
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student under Nephrology Division, Department of Medicine in King Saud University.
Cushing’s Syndrome.
Biochemistry of Addison’s Disease. ANATOMICALLY: The adrenal gland is situated on the anteriosuperior aspect of the kidney and receives its blood supply.
This lecture was conducted during the Nephrology Unit Grand Ground by Registrar under Nephrology Division under the supervision and administration of Prof.
CHAPTER 7 The endocrine system. INTRODUCTION:  There are three components to the endocrine system: endocrine glands; Hormones; and the target cells or.
Armed Forces Academy of Medical Sciences
Morning Report Rick Hobbs PGY – 3.4ish.
+ This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student rotated under Nephrology Division under the supervision and administration.
1 ADRENOCORTICOSTEROIDS Major categories of action: Glucocorticoids: affecting intermediary metabolism & resistance to stress Mineralocorticoids: regulation.
Endocrine Physiology The Adrenal Gland 2
Adrenal gland disorders
Evaluation and Management of the Patient with Hypertension and Hypokalemia Stephen L. Aronoff, MD.
DISORDERS OF THE ADRENOCORTICAL HORMONES Dr. Ayisha Qureshi MBBS, Mphil.
Cushing’s syndrome Zhaoxiaojuan. Effects of glucocorticoid Effects on metabolism Effects on immunologic function and inflammatory Effects on musculoskeletal.
Corticosteroid Therapy in Acute illness Uptodate ICU-Acquired Weakness and Recovery from Critical Illness, N Engl J Med 2014 Hydrocortisone.
Adrenal Cortical Hormones
Adrenocortical hormones
Adrenal Glucocorticoids 7 أ. م. د. وحدة بشير اليوزبكي Head of Department of Pharmacology- College of Medicine- University of Mosul-2014.
Adrenal Crisis Nicole Wilde UNC Morning Report 5/18/10.
Endocrine Physiology The Adrenal Gland 2 Dr. Khalid Al-Regaiey.
Cushing's syndrome Abdullah Alhowidi Definition Cushing's syndrome is a characteristic group of manifestations caused by excessive circulating.
Adrenal insufficiency
Adrenal insufficiency. Objectives At the end of this lecture, the student should be able to: Define adrenal insufficiency Recognize the causes of adrenal.
Date of download: 6/1/2016 From: A Physiologic Approach to Diagnosis of the Cushing Syndrome Ann Intern Med. 2003;138(12): doi: /
Adrenal Disease Alex Edwards
Zona Glomerulosa Zona Fasiculata Zona Reticularis.
Date of download: 6/2/2016 Copyright © 2016 McGraw-Hill Education. All rights reserved. Hypothalamic, pituitary, and adrenal cortical relationships. Solid.
MINERALOCORTICOIDS Dr. Eman El Eter. Hormones of Adrenal gland  Cortex: (Secretes steroid hormones)  Glucocorticoids.  Mineralocorticoids.  Androgens.
Adrenal insufficiency
The cortex consists of 3 layers 1 st is zona granulosa - mineralocorticoids, for example aldosterone. The inner 2 layers are zona fasiculata and zona reticularis.
1 Dr. Wael H.Mansy, MD Assistant Professor College of Pharmacy King Saud University Disorders Of Adrenal Glands.
Copyright © 2016, 2013, 2010 by Saunders, an imprint of Elsevier Inc. All rights reserved. Chapter 60 Drugs for Disorders of the Adrenal Cortex.
Addison’s Disease MS II. Endocrine2 Adrenal Glands Adrenal Medulla – Responds to SNS stimulation – Secretes catecholamines – epinephrine is the main player.
B. Primary adrenal hyperplasia and neoplasms
Endocrine Physiology The Adrenal Gland : Glucocorticoids
Disorders of the Endocrine Glands
Hormones of the Adrenal Cortex
Hypothalamic, pituitary, and adrenal cortical relationships
Hypothalamic, pituitary, and adrenal cortical relationships
DISEASES OF THE ENDOCRINE SYSTEM SUPRARENAL GLAND
Unit IV – Problem 5 – Clinical Disease of Adrenal Gland
Adrenal Disorders (PED474)
Adrenal Insufficiency (AI) in the Septic Patient
Alex Edwards Adrenal Disease Alex Edwards
Use of Mifepristone for Prevention of Adrenal Insufficiency Following
Adrenocorticosteroids
Interventions for Clients with Pituitary and Adrenal Gland Problems
Major Hormone Secreting Glands of the Endocrine System
Presentation transcript:

Adrenal Disorders

The 3 components of the HPA axis function as integral system. Corticotropin-releasing hormone (CRH): *Released from the hypothalamus in response to a variety of stimulants (neurotrasmitters, catecholamines,….) Adrenocorticotropic hormone (ACTH): *Anterior pituitary hormone released into the systematic circulation in response to stimulation by the CRH. *ACTH stimulates the adrenal cortex to produce cortisol. *ACTH also binds to milanocortin-2 receptors, increasing pigment deposition. As serum cortisol levels increase, the biosynthesis & secretion of CRH & ACTH decrease in a negative feedback mechanism.

CIRCADIAN RHYTM: ACTH release is controlled by: 1. CRH 2. Free cortisol plasma conc. 3. The sleep-wake cycle. ACTH plasma conc. peaks early A.M., then decreases, & nadirs @ ~ midnight. Cortisol plasma conc. peaks @ awakening then declines & nadirs 1 or 2 after falling asleep. Stress ( injury, pain, hypoglycemia, hypovolemia, exercise, emotional trauma,…) enhances ACTH release & abolishes ACTH circadian rhythm. High-dose glucocorticoid adm. supresses stress-related ACTH release.

Key Concepts 1. Glucocorticoid secretion from the adrenal cortex is stimulated by adrenocorticotropic hormone (ACTH) or corticotropin that is released from the anterior pituitary in response to the hypothalamic-mediated release of corticotropin-releasing hormone (CRH). 2. To ensure the proper treatment of Cushing's syndrome, diagnostic procedures should (1) establish the presence of hypercortisolism & (2) discover the underlying etiology of the disease. 3. The rationale for treating Cushing's syndrome is to reduce the morbidity & mortality resulting from disorders i.e., diabetes mellitus, cardiovascular disease, & electrolyte abnormalities. 4. The treatment of choice for both ACTH-dependent and ACTH-independent Cushing's syndrome is surgery, whereas pharmacologic agents are reserved for adjunctive therapy, refractory cases, or inoperable disease. 5. Pharmacologic agents that may be used to manage the patient with Cushing's syndrome include steroidogenesis inhibitors, adrenolytic agents, neuromodulators of ACTH release,& glucocorticoid-receptor blocking agents.

6. Spironolactone, a competitive aldosterone receptor antagonist, is the drug of choice in bilateral adrenal hyperplasia (BAH)-dependent hyperaldosteronism. 7. Addison's disease (primary adrenal insufficiency) is a deficiency in cortisol, aldosterone, & various androgens resulting from the loss of function of all regions of the adrenal cortex. 8. Secondary adrenal insufficiency usually results from exogenous steroid use, leading to hypothalamic-pituitary-adrenal (HPA)-axis suppression followed by a decrease in ACTH release, & low levels of androgens & cortisol. 9. Virilism results from the excessive secretion of androgens from the adrenal gland & often manifests as hirsutism in females.

Cushing’s Syndrome

Definition: A disorder caused by persistent glucocorticoid excess. Etiology:(see table2) The increase of serum cortisol by: *ACTH-dependent Disorders Or *ACTH-independent Disorders Cushing’s disease is a specific type of Cushing’s Syndrome caused by ACTH-secreting pituitary tumors. Women develop Cushing’s disease 3-8X > men

Pathophysiology: Cushing’s Syndrome: Results from a prolonged exposure to excessive glucocorticoids. Cushing’s Disease: Pituitary micro- or macroadenomas or hyperplasia increased ACTH secretion (relativ. resistant to glucocorticoid negative feedback)

Ectopic tumors secrete ACTH or CRH  Adrenocortical hyperplasia & hyperfunction. Exogenous adm. of glucocorticoids  Increase serum cortisol  Inhibiting CRH & ACTH secretion  Bilateral adrenocortical atrophy.

Diagnosis & Clinical Findings: Rule out hypercortisolism by: a. iatrogenic (prescribed glucocorticoids) causes. b. surreptitious (nonprescribed glucocort. use w/o intent of self-harm) causes. or c. factitious (nonprescribed glucocort. use w/ intent of self-harm) causes. The definitive test is HPLC analysis of urine for synthetic corticosteroids. 2. Establish the presence of hypercortisolism: HPA axis tests to determine the cause of hypercortisolism.

Differential Diagnosis: Defining the precise cause of Cushing’s syndrome: essential to appropriate surgical management. Plasma ACTH: Elevated w/ ACTH-dependent Cushing’s & low in ACTH-independent. CRH-Stimulation Test: A subnormal response of ACTH to an IV bolus synthetic CRH ACTH-independent Cushing’s syndrome An elevated ACTH to an IV bolus synthetic CRH ACTH-dependent Cushing’s syndrome

Differential Diagnosis (cont.): Metyrapone Test: Sometimes used when other tests are equivocal. It differentiates between Cushing’s disease & ectopic ACTH-secreting tumors. As a response to metyrapone: *Cushing’s disease pts. show a decrease in cortisol. *Ectopic ACTH-secreting tumors pts. show little or no response.

Radiologic Imaging: CT scan is used to: *Determine the location & size of tumors. *Differentiate between adrenal adenomas & carcinomas. CT in pts w/ ACTH-dependent Cushing’s Synd. shows bilateral hyperplastic glands though the adrenals may be normal or atrophic. MRI > sensitive for detecting ACTH-producing pituitary microadenomas than CT scans.

Therapeutic Plan: Tx depends on the etiology. Appropriate Tx  Resolves hypercortisolism SxS over weeks to months. Iatrogenic Cushing’s syndrome Tx: *Slowly tapering the steroids over several wks. *Manage the adverse physiologic consequences of excessive chronic glucocot. adm. (i.e. hyperglycemia, elevated BP). *Monitor for & treat infections *Replace K⁺ *Give Ca supplement *Glucocort. Dosage supplement in acute illness, injury or surgery.

Therapeutic Plan (cont.): Cushing’s dz.: Treated by selective surgical removal of pituitary microadenomas (Transsphenoidal adenectomy). ACTH production temporarily drops after surgery: Pt. requires glucocort. replacement X 3-12 months until HPA-axis recovers.

Therapeutic Plan (cont.) Pituitary irradiation is indicated for those who failed or unable to tolerate pituitary surgery. Ectopic ACTH-secreting tumors, adrenal adenomas, adrenalomas are: 1. Surgically removed Or 2. Treated w/ radiation Or 3. Treated w/ standard chemotherapy * Adrenocorticolytic drugs control cortisol prod. during treatment.

Treatment of Cushing’s Dz.: Pharmacotherapy indicated to: Reduce cortisol production before surgery. Maintain normal plasma cortisol levels while awaiting results of surgery or radiation Tx. Treat pts. w/ severe physical or psychiatric hypercortisolism Sx. 4. Reduce cortisol effects in pts. w/ nonresectable tumors.

3 Categories of Meds. for Cushing’s Syndrome: Steroidogenic Inhibitors: ( Ketoconazole, Metyrapone, Aminoglutethimide, Mitotane, Etomidate ) *Used almost exclusively to treat ACTH- dependent synd. *Most effective agents available for treating Cushing’s synd. Neuromodulators of ACTH Secretion: ( Bromocriptine, Cyproheptadine, Valproate) *Disappointing results. Glucocorticoid Receptor Antagonists: ( Mifepristone ) *Limited clinical experience

Ketoconazole: Is usually the initial Tx. Metyrapone: May be added as a second steroidognic inhibitor. Aminoglutethimide: May be added if the combination of ketoconazole & metyrapone is ineffective. The 3 act synergistically & their S/Es reduced @ < than max. doses of each.

Dexamethasone (0.25-0.5 mg QD): Added as cortisol serum levels approach normal w/ adjusting the dose to alleviate Sx of hypocortisolism. Dexamethasone has advantage over other GCs in: 1. Not interfering w/ serum cortisol assay. & 2. Having a long t1/2 (QD dosing)

Fludrocortisone:. Mineral corticoid. replacement may be Fludrocortisone: *Mineral corticoid replacement may be indicated depending on specific Tx. *Dose adjusted to alleviate SxS of volume depletion, & normalize electrolytes & plasma renin. Coexisting ovulatory disorders make pregnancy rare in Cushing’s synd.:  Tx same as above with consideration of the benefits vs. risks of each drug.

A. Steroidogenic Inhibitors: Ketoconazole: Inhibits cortisol synthesis & ACTH secretion V. effective in lowering cortisol in Cushing’s. Initial Tx: * 200mg p.o. QD & increase @ 4-7d intervals till UFC decrease to upper normal limits. * Tx usually requires 600-800mg QD

Ketoconazole (Cont.): Careful clinical monitoring , including serum drug levels when appropriate, is indicated due to high DI profile. Examples: Ketoconazole inhibits metabolism of drugs i.e. warfarin, phenytoin, … Ketoconazole absorption is decreased by: antacids, H₂ antagonists, sucralfate. 3. Ketoconazole levels are decreased by: isoniazid & rifamin.

2. Metyrapone: * Blocks the synthesis of cortisol. Used to treat Cushing’s: * when dose-limiting ketoconazole S/Es Or * as part of combination therapy w/ other steroidogenic inhibitors. *Initial Dose: *250mg QD *up to 2000 mg QD are well tolerated. * Induces hepatic oxidase (metabolism of phenytoin or phenobarbital)

3. Aminoglutethimide: * Inhibits cortisol synthesis. Short duration of effect. Duration of effects longer w/: 1. Cortisol-secreting adrenocarcinomas Or 2. When used in combination w/ metyrapone or pituitary irradiation. Initial Tx: *250mg QID & *increased as required to normalize UFC conc.(<1g/d) * It induces metabolism of Dexamethasone * Has No effect on cortisone metabolism

4. Mitotane: Inhibits Cortisol synthesis. Used mostly w/ pituitary irradiation. May be used in combination w/ other steroidogenic inhibitors. Most pts. respond to pit. irradiation & do not require chronic mitotane therapy. Initial Tx: 500 mg QD @ bedtime Increased as required to normalize UFC conc.

Mitotane (cont.): Concomitant glucocort. replacement is required during & after therapy ( Mitotane accumulates in fatty tissues & persists in plasma X several months after D/C.) Mitotane induces mineralocorticoid deficiency & Fludrocortisone replacement is guided by SxS of vol. depletion or excess .

5. Etimodate: A hypnotic parenteral anesthetic that inhibits cortisol synthesis @ low & high doses BUT data about its use in Cushing’s is limited. B. Neuromodulators: All were used experimentally in Cushing’s but w/ very limited data & were disappointing. C. Glucocorticoid Receptor Antagonists: Mifepristone use in Cushing’s has limited data. Serum cortisol conc. is unaffected. Concomitant adm. of spironolactone may be required to control hypokalemia secondary to cortisol activation of mineralocorticoid receptors).

Nonpharmacologic Therapy: 1. Surgery: Transsphenoidal microadenomectomy: Surgery of choice for circumscribed microadenomas (cure 95%) Preserves normal anterior pituitary function. ACTH- & CRH- Secreting Tumors Resection: Curative, but most tumors are non-resectable.

c. Bilateral Total Surgical Adrenalectomy: indications: 1 c. Bilateral Total Surgical Adrenalectomy: indications: 1.Bilateral micronodular or macronodular adrenal hyperplasia & non-resectable ectopic tumors. 2. When rapid hypercortisolism reduction is needed. 3. When all other therapies have failed.

Nonpharmacologic Therapy (cont.): 2. Pituitary Irradiation: * Indicated for treating Cushing’s Dz. Not cured by transphenoidal surgery. Newer forms of computer assisted radiotherapy may be more effective but has limited experience. Until remission, hypercortisolism is controlled w/ adrenal enzyme inhibitors, i.e. ketoconazole.

Addison’s Disease

Treatment Goals: 1. Restore HPA hormonal balance by replacing glucocorticoids & mineralocorticoids. 2. Manage hormonal needs during intercurrent illness.

Definition: Addison’s dz. is rare. Also known as primary adrenal insufficiency. Most often caused by autoimmune-mediated destruction of the adrenal cortex. SxS result from Decreased production of : 1. Glucocorticoids 2. Mineralocorticoids 3. Androgens

Etiology: Primary Addison’s: Caused by adrenal gland dz., assoc. w/ Glucocort., mineralocort., & androgen deficiencies. > 90% are autoimmune assoc. Other causes, include: *Infections *Infiltrating dz. ( sarcoidosis,…) *Hemorrhage or infarction *Tumors

2. Secondary Addison’s: Caused by ACTH insufficiency assoc. w/ glucocortic. deficiency; the RAA axis is intact. The most common cause: *Sudden withdrawal of chronic adm. of exogenous glucocorticoids. * Other causes, include: 1. Hypothalamic or pituitary tumors or lesions. 2. Surgical removal of pituitary. 3. Pituitary irradiation. 4. Aneurysm of the internal carotid artery. 5. Proopiomelanocortin (POMC) gene mutation. 6. Drugs that interfere reversibly w/ steroidogenesis.

Pathophysiology: All 3 zones of adrenal gland are progressively destroyed & replaced by fibrotic tissue. The medulla is spared but may be atrophic. Adrenal dysfunction may be gradual or abrupt. SxS appear when ≥90% adrenal cortex is destroyed. Acute adrenal bleeding or infection is assoc. w/ sudden & complete adrenal loss. Autoantibodies directed against adrenal cortex steroid-producing cells are characteristic of Autoimmune Addison’s dz.

Clinical Presentation (cont.): > 90% present w/ biochemical abnormalities, including: * Hyponatremaia * Hyperkalemia * Mild Acidosis * Hypoglycemia * hypercalcemia All of which are opposite from Cushing’s biochemical changes.

Acute Adrenal Crisis: Usually occurs w/ undiagnosed Addison’s & untreated stress. SxS mimic septic shock, including: Anorexia, N/V, sev. dehydration, hypotension, shock unresponsive to vasopressors & inotropics, tachycardia, fever, hypoglycemia, progressively deteriorating mental status, & biochemical changes.

Acute Addison’s Crisis (cont.): May occur in: Previously normal adrenal function(in isolation): Serum Na & K w/in NL limits & NOT hyperpigmented. Superimposed on chronic adrenal insufficiency: Dehydration, hyponatremia, hyperkalemia, wt. loss, & azotemia.

Diagnosis: Establishing Adrenal Insufficiency: Basal Serum Cortisol: *A very low morning serum or salivary cortisol conc. suggests adrenal dysfunction. *A high basal cortisol serum conc. suggests an intact HPA axis.

2. Short ACTH Stimulation Test: Serum Cortisol is measured before & 30-60min after IM or IV short ACTH adm.: Addison’s is Ruled Out if pk. Cortisol conc. >19mcg/dL. It Does: *NOT exclude mild 1⁰or 2⁰ Addison’s. *NOT distinguish between 1⁰ & 2⁰ Addison’s. *Not always predict the response to stress.

Differential Diagnosis: 1. Basal Plasma ACTH: * Normally, Plasma ACTH conc. Is highest @ 8A.M. & lowest @ midnight. * Very high 8 A.M. plasma ACTH establishes 1⁰ adrenal insufficiency. * Low or low normal Basal plasma ACTH establishes 2⁰ adrenal insufficiency.

2. Two-day ACTH Stimulation Test: When ACTH is infused over 8 hrs. on 2 consecutive days: * In 1⁰ Addison’s, serum cortisol & UFC are low & do NOT ↑with time. * In 2⁰ adrenal insufficiency, serum cortisol & UFC are increased @ 24 & 48 hrs.

3. Insulin-Induced Hypoglycemia: Hypoglycemia (BS < 40mg/dL) stimulates HPA. a. Cortisol & BS are measured @ baseline. b. IV Regular insulin is adm. then cortisol & BS are measured every 15 min. for 90 min. c. Adrenal insufficiency is suggested if: plasma cortisol <18-20 mcg/dL @ 60-90min.

4. RAA: *Plasma renin is increased & plasma aldosterone is decreased in 1⁰ adrenal insufficiency BUT Normal in 2⁰ adrenal insufficiency 5. CT & MRI: *May also be helpful

Therapeutic Plan: * Addison’s Dz. Tx consists of : a. Hormone replacement therapy. & b. Supplemental glucocorticoid therapy during stress periods. Replacement Glucocort. & Mineralocort. therapy is continued indefinitely. Some cases of subclinical autoimmune adrenal insufficiency may be self-limiting. Androgen replacement therapy may be considered ( NOT routinely recommended ).

Treatment: Pharmacotherapy: Chronic Replacement Therapy: 1. Dexamethasone: * Currently the glucocorticoid of choice for: a. Chronic replacement therapy b. Patient-initiated rescue therapy c. Initial Tx of an adrenal crisis before the diagnosis is confirmed.

2. Fludrocortisone: * The mineralocorticoid of choice for chronic replacement therapy. Approx. equipotent w/aldosterone but is only available p.o. * Dose is titrated to: *relieve postural hypotension symptoms *normalize standing & sitting BP *normalize serum K & plasma renin

The Current Recommendation: Dexamethasone 0.5mg (0.25-0.75mg) + Fludrocortisone 0.1mg (0.05-0.2mg) QD @ HS Doses are individualized to clinical response. If caused insomnia: Take the glucocort. when arise in A.M. Some pts. need a small (5-10mg) mid-afternoon supplemental Hydrocortisone dose. * For women, whose main source of androgens are the adrenals: Androgen replacement therapy w/ Dehydroepiandrosterone ( DHEA ) (25-50 mg QD ) may improve the mood & sense of well-being ( Not well established ), but w/ high incidence of S/Es: sweat odor, acne, hirsutism, …

Acute Adrenal Crisis: Life-threatening Empiric GC replacement therapy & supportive therapy must be started before Dx is confirmed. Hydrocotisone: DOC for the acute Tx or for short-term parenteral use. Concomitant mineralocort. replacement therapy is not necessary when large doses of hydrocortisone are adm. because HC has ~ 1% of aldosterone mineral activity.

The GC dose is titrated to relieve clinical SxS *Acute Adrenal Crisis (cont.) : The GC dose is titrated to relieve clinical SxS & normalize the morning plasma ACTH. HC is tapered to maintenance doses over 1-3 days as the precipitating illness resolves. Mineralcort. deficiency is treated w/: Saline + Fluid loading (Aldosterone replacement therapy is NOT effective since it takes several days for Na-retaining effect to be seen)

Acute Adrenal Crisis (cont.) : Once pt. is stable, IV fluids are continued @ lower rate X 1-2 days. Fludrocortisone (mineralocort.replace.therapy): started when the pt. is stable & able to take p.o. meds.

Supplemental Stress-Dose Steroids: Physiologically stressed Addison’s dz. pts. by acute medical illness or trauma need supplemental steroids. For special situations: See table

Nonpharmacologic Therapy: For normotensive pts. consists of: a. Liberalizing dietary salt intake. b. Avoidance of Na-wasting diuretics & spironolactone. * Hypertensive pts. should be maintained on salt-restricted diets.